Logo image
SIRT3 DEACETYLATES AND INCREASES PYRUVATE DEHYDROGENASE ACTIVITY IN CANCER CELLS
Journal article   Peer reviewed

SIRT3 DEACETYLATES AND INCREASES PYRUVATE DEHYDROGENASE ACTIVITY IN CANCER CELLS

Ozkan Ozden, Seong-Hoon Park, Brett A Wagner, Ha Yong Song, Yueming Zhu, Athanassios Vassilopoulos, Barbara Jung, Garry R Buettner and David Gius
Free radical biology & medicine, Vol.76, pp.163-172
11/2014
DOI: 10.1016/j.freeradbiomed.2014.08.001
PMCID: PMC4364304
PMID: 25152236

View Online

Abstract

Pyruvate dehydrogenase E1 alpha (PDHE1α or PDHA1) is the first component enzyme of the pyruvate dehydrogenase (PDH) complex (PDC) that transforms pyruvate, via pyruvate decarboxylation, into acetyl-CoA that is subsequently used by both the citric acid cycle and oxidative phosphorylation to generate ATP. As such, PDH links glycolysis and oxidative phosphorylation in normal as well as cancer cells. Herein we report that SIRT3 interacts with PDHA1 and directs its enzymatic activity via changes in protein acetylation. SIRT3 deacetylates PDHA1 lysine 321 (K321) and a PDHA1 mutant, mimicking a deacetylated lysine ( PDHA1 K321R ) increases in PDH activity, as compared to the K321 acetylation mimic ( PDHA1 K321Q ) or wild-type PDHA1 . Finally, PDHA1 K321Q exhibited a more transformed in vitro cellular phenotype as compared to PDHA1 K321R . These results suggest that the acetylation of PDHA1 provides another layer of enzymatic regulation, in addition to phosphorylation, involving a reversible acetyl-lysine suggesting that the acetylome, as well as the kinome, links glycolysis to respiration.
Pyruvate dehydrogenase Warburg PDHA1 Acetylation Carcinogenesis SIRT3

Details

Metrics

Logo image